A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders

Res Pract Thromb Haemost. 2020 Oct 28;4(8):1340-1342. doi: 10.1002/rth2.12444. eCollection 2020 Nov.

¹ Division of Hematology Massachusetts General Hospital Harvard Medical School Boston MA USA.
² Division of Hematology Johns Hopkins University Baltimore MD USA.
³ Department of Medicine Department of Pathology & Laboratory Medicine Larner College of Medicine at the University of Vermont Burlington VT USA.

No abstract available

Keywords: HHT; Osler‐Weber‐Rendu; blood transfusion; clinical trials; hereditary hemorrhagic telangiectasia; intravenous iron.